These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
396 related items for PubMed ID: 18775757
1. Involvement of CRH receptors in urocortin-induced hyperthermia. Telegdy G, Adamik A. Peptides; 2008 Nov; 29(11):1937-42. PubMed ID: 18775757 [Abstract] [Full Text] [Related]
2. The action of urocortins on body temperature in rats. Telegdy G, Adamik A, Tóth G. Peptides; 2006 Sep; 27(9):2289-94. PubMed ID: 16650509 [Abstract] [Full Text] [Related]
3. Increase of core temperature induced by corticotropin-releasing factor and urocortin: a comparative study. Figueiredo MJ, Fabricio AS, Machado RR, Melo MC, Soares DM, Souza GE. Regul Pept; 2010 Dec 10; 165(2-3):191-9. PubMed ID: 20691217 [Abstract] [Full Text] [Related]
4. The effects of CRF and the urocortins on [3H]GABA release from the rat amygdala--an in vitro superfusion study. Bagosi Z, Jászberényi M, Szabó G, Telegdy G. Brain Res Bull; 2008 Jan 31; 75(1):15-7. PubMed ID: 18158090 [Abstract] [Full Text] [Related]
5. Peripheral and central administration of exogenous urocortin 1 disrupts the fasted motility pattern of the small intestine in rats via the corticotrophin releasing factor receptor 2 and a cholinergic mechanism. Yin Y, Dong L, Yin D. J Gastroenterol Hepatol; 2008 Jul 31; 23(7 Pt 2):e79-87. PubMed ID: 17944898 [Abstract] [Full Text] [Related]
6. Human urocortin II, a new CRF-related peptide, displays selective CRF(2)-mediated action on gastric transit in rats. Million M, Maillot C, Saunders P, Rivier J, Vale W, Taché Y. Am J Physiol Gastrointest Liver Physiol; 2002 Jan 31; 282(1):G34-40. PubMed ID: 11751155 [Abstract] [Full Text] [Related]
7. Urocortin I is present in the enteric nervous system and exerts an excitatory effect via cholinergic and serotonergic pathways in the rat colon. Kimura T, Amano T, Uehara H, Ariga H, Ishida T, Torii A, Tajiri H, Matsueda K, Yamato S. Am J Physiol Gastrointest Liver Physiol; 2007 Oct 31; 293(4):G903-10. PubMed ID: 17717045 [Abstract] [Full Text] [Related]
9. Neuropeptide urocortin and its receptors are expressed in rat Kupffer cells. Charalampopoulos I, Androulidaki A, Minas V, Chatzaki E, Tsatsanis C, Notas G, Xidakis C, Kolios G, Kouroumalis E, Margioris AN, Gravanis A. Neuroendocrinology; 2006 Oct 31; 84(1):49-57. PubMed ID: 17090973 [Abstract] [Full Text] [Related]
10. Participation of corticotropin-releasing factor type 2 receptors in the acute, chronic and withdrawal actions of nicotine associated with feeding behavior in rats. Kamdi SP, Nakhate KT, Dandekar MP, Kokare DM, Subhedar NK. Appetite; 2009 Dec 31; 53(3):354-62. PubMed ID: 19635511 [Abstract] [Full Text] [Related]
11. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland. Okada R, Miller MF, Yamamoto K, De Groef B, Denver RJ, Kikuyama S. Gen Comp Endocrinol; 2007 Feb 31; 150(3):437-44. PubMed ID: 17188689 [Abstract] [Full Text] [Related]
12. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists. de Groote L, Peñalva RG, Flachskamm C, Reul JM, Linthorst AC. J Neurochem; 2005 Jul 31; 94(1):45-56. PubMed ID: 15953348 [Abstract] [Full Text] [Related]
13. Peripheral urocortin delays gastric emptying: role of CRF receptor 2. Nozu T, Martinez V, Rivier J, Taché Y. Am J Physiol; 1999 Apr 31; 276(4):G867-74. PubMed ID: 10198329 [Abstract] [Full Text] [Related]
14. Urocortin 1 inhibits guinea pig gallbladder contractility in vitro via corticotropin-releasing factor receptor 2. Abd El-Aziz SM, Abdel-Wahab BA. Can J Physiol Pharmacol; 2011 Nov 31; 89(11):783-91. PubMed ID: 22007876 [Abstract] [Full Text] [Related]
15. Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats. Maillot C, Million M, Wei JY, Gauthier A, Taché Y. Gastroenterology; 2000 Dec 31; 119(6):1569-79. PubMed ID: 11113078 [Abstract] [Full Text] [Related]
16. Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands. Krause K, Schnitger A, Fimmel S, Glass E, Zouboulis CC. Horm Metab Res; 2007 Feb 31; 39(2):166-70. PubMed ID: 17326013 [Abstract] [Full Text] [Related]
17. Urocortin 2 acts centrally to delay gastric emptying through sympathetic pathways while CRF and urocortin 1 inhibitory actions are vagal dependent in rats. Czimmer J, Million M, Taché Y. Am J Physiol Gastrointest Liver Physiol; 2006 Mar 31; 290(3):G511-8. PubMed ID: 16223946 [Abstract] [Full Text] [Related]
18. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors. Perrin MH, Sutton SW, Cervini LA, Rivier JE, Vale WW. J Pharmacol Exp Ther; 1999 Feb 31; 288(2):729-34. PubMed ID: 9918582 [Abstract] [Full Text] [Related]
19. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors. Singh LK, Boucher W, Pang X, Letourneau R, Seretakis D, Green M, Theoharides TC. J Pharmacol Exp Ther; 1999 Mar 31; 288(3):1349-56. PubMed ID: 10027877 [Abstract] [Full Text] [Related]
20. The role of central corticotropin-releasing hormone in the anorexic and endocrine effects of the bacterial T cell superantigen, Staphylococcal enterotoxin A. Kaneta T, Kusnecov AW. Brain Behav Immun; 2005 Mar 31; 19(2):138-46. PubMed ID: 15664786 [Abstract] [Full Text] [Related] Page: [Next] [New Search]